Draw
|
Currency :
Structure Search
AG001BO5
139755-83-2 | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-
![Chemical structure of 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-, CAS 139755-83-2](https://api.angenesci.com/structure/312/139755-83-2.png)
AG001BO5
SDS
COATIP
This product is typically in stock.Please contact us for
quotation.
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
- mg
- g
- kg
- ml
- L
无数据
无数据
| CAS Number | 139755-83-2 |
| Catalog Number | AG001BO5(AGN-PC-050FRZ) |
| Chemical Name | 7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl- |
| EC Number | 604-158-7 |
| IUPAC Name | 5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one |
| InChI | InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29) |
| InChI Key | BNRNXUUZRGQAQC-UHFFFAOYSA-N |
| MDL Number | MFCD00867528 |
| Molecular Formula | C22H30N6O4S |
| Molecular Weight | 474.5764 |
| SMILES | C(C)OC1=C(C=C(C=C1)S(=O)(=O)N1CCN(CC1)C)C=1NC(C2=C(N1)C(=NN2C)CCC)=O |
| UNII | 3M7OB98Y7H |
| Synonyms | 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate,
acetildenafil,
Citrate, Sildenafil,
desmethyl sildenafil,
desmethylsildenafil,
homosildenafil,
hydroxyhomosildenafil,
Lactate, Sildenafil,
NCX 911,
NCX-911,
NCX911,
Nitrate, Sildenafil,
Revatio,
sildenafil,
sildenafil citrate,
sildenafil lactate,
sildenafil nitrate,
Sildenafil, Desmethyl,
UK 92,480 10,
UK 92480 10,
UK 92480-10,
UK 9248010,
UK-92,480-10,
Viagra,
sildenafil,
139755-83-2,
Revatio,
VIAGRA,
Sildenafil [INN:BAN],
UK-92480,
UNII-3M7OB98Y7H,
UK-92,480-10,
C22H30N6O4S,
HSDB 7305,
CHEMBL192,
3M7OB98Y7H,
CHEBI:9139,
UK 92480-10,
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine,
BNRNXUUZRGQAQC-UHFFFAOYSA-N,
5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one,
5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one,
NCX-911,
5-{2-ETHOXY-5-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-1-METHYL-3-PROPYL-1H,6H,7H-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE,
1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate,
Aphrodil (TN),
5-[2-ethoxy-5-(4-methyl-1-piperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one,
5-{2-(ethyloxy)-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one,
Piperazine, 1-((3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl-,
Sildenafil (INN),
SMR000752512,
SR-05000001934,
NCGC00159496-02,
Vizarsin,
Sildenafil#,
1udt,
1xos,
1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine,
5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one,
5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one,
5-[2-ethoxy-5-(4-methylpiperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo(4,3-d]pyrimidin-7-one,
5-[2-ethoxy-5-(4-methylpiperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one,
Spectrum_001555,
SpecPlus_000798,
AC1L1JUI,
Spectrum2_001648,
Spectrum3_001892,
Spectrum4_000586,
Spectrum5_001508,
Cambridge id 7030299,
SCHEMBL1895,
BSPBio_003424,
KBioGR_001052,
KBioSS_002035,
MLS001240224,
MLS001304737,
MLS006011565,
BIDD:GT0352,
DivK1c_006894,
SPECTRUM1504099,
SPBio_001775,
GTPL4743,
SCHEMBL5795456,
SCHEMBL8100377,
Jsp002373,
DTXSID6023579,
BDBM14390,
KBio1_001838,
KBio2_002035,
KBio2_004603,
KBio2_007171,
KBio3_002927,
KS-00000XMX,
2h42,
HMS1684K08,
HMS1922B19,
HMS2089M12,
HMS2093O17,
HMS2233L22,
HMS3372N07,
HMS3715P17,
Sildenafil 1.0 mg/ml in Methanol,
ACT02662,
BCP05337,
AC-938,
CCG-21806,
CCG-39076,
MFCD00867528,
s4684,
STL483201,
STL483720,
ZINC19796168,
AKOS008901403,
AKOS025397193,
CS-1577,
DB00203,
MCULE-2481702478,
SB17345,
NCGC00095099-01,
NCGC00095099-02,
NCGC00095099-03,
NCGC00095099-04,
NCGC00370976-03,
5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one,
AN-15436,
AS-48884,
BAS 04213629,
BC202768,
HY-15025,
M901,
SC-83326,
SMR004703325,
SBI-0051920.P002,
AB0015440,
LS-111655,
FT-0601554,
C07259,
D08514,
W-2194,
AB00052444-02,
AB00052444-03,
AB00052444_04,
AB00052444_05,
755S832,
SR-01000504734,
I06-0023,
J-007309,
SR-01000504734-1,
SR-05000001934-1,
SR-05000001934-2,
BRD-K50128260-001-01-6,
BRD-K79759585-001-02-1,
BRD-K79759585-048-01-4,
4-((4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydr,
Z1522567175,
Sildenafil solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material,
5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one,
5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one,
5-[2-Ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one,
5-[2-Ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1-methyl-3-n-propyl-1.6-dihydro-7H-pyrazolo[4,3-d]Pyrimidin-7-one,
5-[2-ethoxy-5-(4-methylpiperazine-1-sulfonyl)phenyl]-1-methyl-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one,
5-[2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one,
5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one,
5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one,
5-{2-ethoxy-5-[(4-methylpiperazine-1-)sulfonyl]phenyl}-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one,
Sildenafil citrate,
acetildenafil,
homosildenafil,
mysildecard,
Aphrodil,
Caverta,
Rhucin,
sildenafil lactate,
sildenafil nitrate,
desmethylsildenafil,
desmethyl sildenafil,
hydroxyhomosildenafil,
Citrate, Sildenafil,
Lactate, Sildenafil,
Nitrate, Sildenafil,
Revatio (TN),
Rhucin (TN),
Viagra (TN),
Sildenafil, Desmethyl,
N-Desmethyl Sildenafil,
D08KTT,
D0Z7ZM,
NCX911,
CID5212,
NCX 911,
C22-H30-N6-O4-S,
Pfizer brand 1 of sildenafil citrate,
Pfizer brand 2 of sildenafil citrate,
ACN-032039,
CS-O-31711,
Sildenafil, 99% - 100MG 100mg,
3132B,
UK 9248010,
UK 92480 10,
A12631,
UK 92,480 10,
C101426,
D000068677,
5-(2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one,
VIA,
1094598-75-0,
5-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phenyl]-1-methyl-3-propyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one (Sildenafil or Viagra),
5-[2-Ethoxy-5-(4-methyl-piperazine-1-sulfonyl)-phenyl]-1-methyl-3-propyl-1,6-dihydro-pyrazolo[4,3-d]pyrimidin-7-one(Sildenafil),
7H-Pirazol [4,3-d pirimidin]-7-ona, 5-[2-etoxi-5-[(4-metil-1-piperacinil)] sulfonilo fenil]-1,6-dihidro-1-metil-3-propil-,
|
| Complexity | 838 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 474.205g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 33 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 474.58g/mol |
| Monoisotopic Mass | 474.205g/mol |
| Rotatable Bond Count | 7 |
| Topological Polar Surface Area | 118A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 1.5 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
| Hazard Class | \N |
| Hazard statements | H315-H319-H335 |
| Packing Group | \N |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code | \N |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited